Tenet Healthcare (THC) Releases FY18 Earnings Guidance

Tenet Healthcare (NYSE:THC) issued an update on its FY18 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $1.07-1.36 for the period, compared to the Thomson Reuters consensus estimate of $1.38. The company issued revenue guidance of $17.8-18.2 billion, compared to the consensus revenue estimate of $18.61 billion.

Tenet Healthcare (THC) traded up $0.66 during mid-day trading on Thursday, hitting $15.43. 1,863,800 shares of the company were exchanged, compared to its average volume of 2,820,000. The stock has a market capitalization of $1,560.00, a price-to-earnings ratio of -2.81, a PEG ratio of 2.13 and a beta of 1.17. Tenet Healthcare has a 1 year low of $12.25 and a 1 year high of $22.72. The company has a debt-to-equity ratio of 21.21, a quick ratio of 1.21 and a current ratio of 1.28.

Tenet Healthcare (NYSE:THC) last released its earnings results on Monday, November 6th. The company reported ($0.17) earnings per share for the quarter, topping the consensus estimate of ($0.40) by $0.23. The business had revenue of $4.59 billion during the quarter, compared to the consensus estimate of $4.94 billion. Tenet Healthcare had a negative return on equity of 5.61% and a negative net margin of 2.85%. The business’s revenue for the quarter was down 5.4% compared to the same quarter last year. During the same period last year, the company earned $0.16 earnings per share. research analysts anticipate that Tenet Healthcare will post 0.69 EPS for the current fiscal year.

THC has been the topic of several research reports. Mizuho restated a neutral rating and set a $14.00 price target on shares of Tenet Healthcare in a research note on Thursday, September 14th. JPMorgan Chase & Co. lowered Tenet Healthcare from a neutral rating to an underweight rating and set a $15.00 target price on the stock. in a research note on Thursday, December 14th. Jefferies Group restated a buy rating and set a $24.00 price target on shares of Tenet Healthcare in a research note on Thursday, September 21st. Royal Bank of Canada dropped their price target on Tenet Healthcare from $19.00 to $17.00 and set a sector perform rating on the stock in a research note on Monday, November 13th. Finally, SunTrust Banks set a $15.00 price target on Tenet Healthcare and gave the stock a hold rating in a research note on Sunday, October 15th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and seven have assigned a buy rating to the stock. The stock has an average rating of Hold and a consensus price target of $18.87.

ILLEGAL ACTIVITY NOTICE: “Tenet Healthcare (THC) Releases FY18 Earnings Guidance” was originally reported by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at https://stocknewstimes.com/2018/01/11/tenet-healthcare-thc-issues-fy18-earnings-guidance.html.

About Tenet Healthcare

Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.

Earnings History and Estimates for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply